KENNETH HERRMANN: Open Payments
NPI 1760433536 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,388 in 57 payments from 16 companies in 2025. Trend: 2023 $8,004 · 2024 $5,442 · 2025 $8,388
Speaker / faculty: $6,650Food & beverage: $1,562Travel & lodging: $176
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $7,245 |
| Janssen Pharmaceuticals, Inc | 3 | $333 |
| E.R. Squibb & Sons, L.L.C. | 6 | $181 |
| Vanda Pharmaceuticals Inc. | 5 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Alkermes, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Collegium Pharmaceutical, Inc. | 3 | $48 |
| Lundbeck LLC | 2 | $42 |
Products named: VRAYLAR, SPRAVATO, COBENFY, FANAPT, TRINTELLIX, REXULTI, LYBALVI, HETLIOZ.
Industry payments across WI — which companies pay providers there.
